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Abstract
Periodontal disease is a polymicrobial disease affecting 10-15% of the population.
Periodontal disease affects the quality of life by reducing mastication and potentially causing
tooth loss. Periodontal disease is also linked to more severe, systemic diseases such as
cardiovascular disease and rheumatoid arthritis. Development of the diseased state occurs when
the plaque biofilm shifts from healthy to dysbiotic. The shift to a dysbiotic biome brings with it a
shift in bacterial presence, specifically an increase in gram-negative bacteria, such as T.
denticola. T. denticola is a gram-negative, anaerobic spirochete whose relationship with oral
epithelial cells is poorly understood. Preliminary data shows an increase in interleukin-36g (IL36g) gene expression when human immortalized gingival keratinocytes are infected with T.
denticola 35405. In this study, we look at IL-36g cytokine production in gingival keratinocytes
infected with T. denticola and begin to uncover the mechanism through which IL-36g signaling
is conducted.
Initially, we established IL-36g gene expression is increased with an increasing
multiplicity of infection when HIGK cells are infected with T. denticola 35405, with expression
being highest at MOI 200. Upon establishing IL-36g expression in response to 35405, we
established that IL-36g is also upregulated in response to multiple T. denticola strains. In order to
begin to investigate the signaling mechanism of IL-36g, a time point for which the highest IL-36g
expression occurred needed to be established. After establishment of this time point, we began
looking for signaling receptors known to activate an innate immune response in response to T.
denticola. We found TLR2 to be upregulated during IL-36g increased expression. Suppression of
TLR2 using siRNA limited IL-36g expression, establishing it plays a role in IL-36g signaling.
Further research into signaling molecules downstream of TLR2 will help to better understand
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how T. denticola induces an inflammatory response and further our understanding of the role IL36g plays in periodontal tissue destruction.
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Chapter 1: Introduction and Background Knowledge
1.1 Periodontal Disease
Periodontal disease is a collective term used to describe the inflammatory changes of the
tooth-supporting structures, such as gingiva, the alveolar bone, the periodontal ligament, and the
root cementum, that may lead to tissue destruction, reduced tooth support, and ultimately tooth
loss (2). Periodontal disease is a polymicrobial disease and is among the most common
infectious diseases among humans (3, 4). Periodontal disease affects 10-15% of the population
and is the leading cause of tooth loss in patients over the age of 35 (3, 4). In 2015, severe tooth
loss accounted for 67% of productivity loss globally, referring to an individual’s decrease in
work productivity due to absence, or while at work due to the illness (5, 6). This amounted to an
astounding 126 billion dollars, and an additional 38 billion dollars lost to severe periodontitis
alone (5). Early periodontitis or gingivitis which is inflammation of the gingiva without loss of
connective tissue can be managed via non-surgical procedures such as scaling and root planing,
and local or systemic antibiotic aids aimed at controlling inflammation (2, 7). The relatively
silent nature of early periodontal disease, combined with low periodontal health awareness leads
to mainly symptom-driven care sought by patients (8). However, failure to resolve periodontal
inflammation may require surgical intervention focusing on the elimination of the periodontal
pocket or modification of alveolar bone, creating better access for at-home care (4).
It has become evident that the oral cavity can act as a source for pathogenic organisms for
distant body sites, specifically for immunocompromised individuals (9). Periodontal disease
affects the quality of life by reducing mastication, aesthetic appeal, and induction of tooth loss
(4). Aside from the direct effects associated with periodontal disease, periodontal disease has
been linked to multiple systemic diseases including cardiovascular disease, diabetes mellitus,
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preterm low-birth-weight, and rheumatoid arthritis among many others (4). Rheumatoid arthritis
is an inflammatory disorder that often leads to physical impairment, resulting in plaque
accumulation and inflammatory periodontal disease due to improper oral hygiene (10, 11).
Periodontal disease has been associated as an independent risk factor for acute myocardial
infarction, peripheral vascular disease, and cerebrovascular disease (12). Patients with
periodontal disease have been found to have increased levels of fibrinogen, TNF-a, and IL-6
among other factors associated with cardiovascular disease. Also, periodontal pathogens have
been found in atherosclerotic plaques, furthering the relationship between periodontal disease
and cardiovascular disease (12).
Periodontal disease can be broken down into many classifications starting with gingival
diseases which are described as pathological alterations to the gingiva, not yet resulting in loss of
support, and are induced by bacterial plaque or may be due to non-plaque related origins (2, 13).
Periodontitis is when gingival disease progresses to loss of tissue support whether it be bone or
the gingiva, and can be broken down into two forms, chronic and aggressive (2, 13). Chronic
periodontitis is the most common form and is proportional to the levels of plaque accumulation
(2, 13). Chronic periodontitis is often slow in progression with increasing age (2, 13, 14).
Aggressive periodontitis is a destructive form that is characterized by rapid bone and attachment
loss, and clusters in families suggesting its pathology is strongly associated with genetic factors
(2, 13). The fourth category of periodontal disease is periodontitis as a manifestation of systemic
disease, involving several diverse conditions including hematological disorders and various
genetic syndromes(2, 13). Necrotizing periodontal disease manifests as necrotizing ulcerative
gingivitis if lesions are confined to soft tissue or necrotizing ulcerative periodontitis where
lesions result in the loss of tissue support (2, 13). Both of these conditions of necrotizing
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periodontal disease are associated with painful necrotic lesions harboring periodontal spirochetes
(2, 13). Abscesses of the periodontium are localized lesions characterized by pronounced
inflammation, swelling, and frequent exudate (2, 13). Though there can be an argument for
abscesses not being their own distinct form of periodontal disease because they can occur during
any of the other types of periodontal disease, they have a distinct clinical appearance and specific
therapeutic requirements (2). Periodontitis associated with endodontic lesions bear characteristics
of other periodontal lesions, but their origin is due to an endodontic infection spreading into
periodontal tissue through the apical foramen (2, 13). The final category is development or
acquired abnormalities and conditions, including various anatomical defects either predisposing
patients to the development of periodontitis or develop as a result of pathology (2, 13).
Chronic periodontitis is defined as the loss of connective tissue and alveolar bone
support of the teeth that is a result of both the direct activity of pathogenic bacteria and plaqueinduced inflammation (2, 13). Chronic periodontitis is the most advanced form of periodontitis,
most prevalent in adulthood, with varying severities (13, 15). Periodontal disease is diagnosed
based on visual cues such as pocket depth using a periodontal probe and radiographic
assessment, as well as more extensive methods that have recently emerged looking into a
patient’s unique genetic susceptibility to periodontal disease (15, 16). Some clinical signs of
periodontitis induced when probing the gingival pocket are bleeding, gum recession, and loose
teeth (13). The rate of progression from healthy gingiva to periodontitis may be influenced by
genetic susceptibility, smoking, lack of home care, age, diet, medications, subgingival placed
fillings or crowns, diabetes, and stress (13, 15). With the progression from healthy periodontium
to a diseased state, there is a shift from mostly gram-positive to mostly gram-negative bacteria
(17). Periodontal disease is initiated by a local accumulation of bacteria over days or weeks

9

Blake
without disruption, known as dental plaque, and the bacteria’s metabolic products that stimulate
the production of tissue-destructive proteinases (13, 18). These proteinases degrade the
junctional epithelium of gingival keratinocytes along the root surface of the tooth apically, the
periodontal ligament, leading to deeper periodontal pockets (Figures 1-1, 1-2) (13).
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Figure 1-1. Progression of periodontal disease
Progression of periodontal disease from healthy periodontium, to gingivitis, to periodontitis
showing plaque buildup, gingival inflammation, loss of gingival attachment, and loss of alveolar
bone which can ultimately lead to tooth loss. Created with BioRender.com.
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Figure 1-2. Plaque formation and deepening of the periodontal pocket
Comparison of healthy to diseased state with plaque and calculus buildup resulting in bone
resorption and deepening of the periodontal pocket as plaque proliferates apically along the
tooth. Created with BioRender.com.
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1.2 Treponema denticola and biofilm formation
Dental plaque, also known as the plaque biofilm, is a dense community of
microorganisms that is tightly adherent to the tooth surface (2, 16, 19). Periodontitis-associated
plaque always extends onto the cementum of the tooth root surface and is usually thicker than
plaque associated with gingivitis (2, 13). Bacterial attachment is dependent on receptors in a thin
salivary coating of the tooth called the acquired pellicle. The acquired pellicle is a mixture of
host and bacterial products. Adhesion can occur through multiple nonspecific mechanisms such
as ionic, hydrophobic, or van der Waals interactions between the pellicle and tooth surface, and
through specific or stereochemical interactions from bacteria to the acquired pellicle mediated by
specialized bacterial surface proteins (2, 19). The stages of plaque development start with the
presence of the acquired enamel pellicle which naturally occurs following cleansing of teeth. The
first bacteria to attach to the acquired pellicle are mostly streptococci, and with time the bacterial
components of the biofilm become more diverse with changes in the environment. Surrounding
the bacteria in the biofilm is a matrix made of host and bacterial products, mostly long-chain
polysaccharides that are responsible for biofilm adhesiveness (2, 19). The first colonizers then
establish the ability for other bacteria to attach through protein or glycan interactions inducing
biofilm growth and maturation. Bacteria proliferate by obtaining their nutrition through the
metabolization of host products or dietary elements (2). Maturation is dependent on two forms of
adhesion, coaggregation and coadhesion. Coaggregation is the binding of two bacterial species in
suspension resulting in clumping, and coadhesion is adherence between one bacterium in
suspension adhering to an already adhered bacterium (Figure 1-3) (2). It is when this acquired
pellicle shifts to a dysbiotic form and a loss of balance between the biofilm and host immune
response that there is an induction of the disease state (8, 18). As the biofilm progresses into a
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more dysbiotic state, the prevalence of gram-negative and filamentous bacteria increases due to
the development of a more suitable environment for these bacteria to thrive (2, 3). With biofilm
progression, there is a transitional zone that establishes where these bacteria thrive, and the
environment progresses from aerobic to anaerobic (2). The change in environment increases the
competitiveness of pathogens at the expense of bacterial species associated with oral health (20,
21). The bacteria in dental plaque release cell wall products inducing host immune cell response
and production of pro-inflammatory cytokines, such as IL-6, TNF-a, and IL-1β (4, 9). This
initial gingival inflammation is a protective mechanism against bacterial invasion (9). Changes in
oxygen levels and pH may not be beneficial to the early colonizing bacteria but may promote the
growth of other anaerobic species (20). Of these anaerobic bacteria, spirochetes eventually grow
to predominance in serum and the biofilm-rich environment neighboring inflamed tissue (21).
A spirochete is a spiral-shaped bacterium with periplasmic flagella originating at opposite
poles and overlapping near the middle of the cell (Figure 1-4)(2, 21). Spirochetes as a whole
have been recognized to make up 20 to 50 percent of the bacterial count in inflamed pockets, as
compared to their relatively minimal presence in healthy oral microbiota (2, 21). Among these,
Treponema denticola is present at a much higher rate than in healthy subjects and has the
strongest association to advanced and progressive periodontitis among other treponemes (21). T.
denticola is a gram-negative, late colonizer found at the leading edge of the plaque biofilm
(Figure 1-5) (9, 21, 22). Gram-negative bacteria possess a lipopolysaccharide outer coating
which affects how they adhere to target tissues, as well as possessing the ability to alter the
hydrophobic properties of this layer and mutate porin size (2, 23). This outer coating specific to
gram-negative bacteria plays a major role in their antibiotic resistance. Many antibiotics must
enter bacteria to access their targets, however, due to this coating antibiotics cannot enter these
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bacteria making them hard to target pharmacologically (23). T. denticola is among the best
characterized and most highly-studied species of treponeme and is acknowledged as a
periodontal pathogen that is found deep within the periodontal pocket in close contact with
neutrophils (3, 24). T. denticola possesses a specific proteinase, dentilisin, that it uses to migrate
through host membranes by cleaving laminin, fibronectin, and collagen (2, 22). Dentilisin is a
chymotrypsin-like protease that is a major contributor to T. denticola virulence by cleaving
human proteins involved in immune response (2, 24, 25). Major surface protein (Msp) is another
major contributor to T. denticola virulence (25, 26). Msp is highly immunogenic and mediates
extra-cellular matrix binding of T. denticola (25, 26). T. denticola is asaccharolytic, meaning it
does not rely on carbohydrates as its fuel source, and instead cleaves host proteins using
dentilisin (27). T. denticola has the ability to modify or degrade chemokines and other
inflammatory mediators to interrupt host immune response (21). It has been shown that
interleukin-8 response to T. denticola is suppressed most likely due to T. denticola degradation
of this secreted product, although this mechanism is not fully understood (17, 21).
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Figure 1-3. Development of plaque biofilm
Formation of the plaque biofilm starting with formation of the acquired enamel pellicle,
streptococci adherence, coaggregation, and maturation and proliferation further growing
the biofilm. Created with BioRender.com.
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Figure 1-4. Treponema denticola
Dark field microscope image of Treponema denticola showing its structure as a
spirochete.
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Figure 1-5. Treponema denticola as a late colonizer
Proliferation of the plaque biofilm in the periodontal pocket with increasing pocket depth
and Treponema denticola emerging as a late colonizer. Created with BioRender.com.
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1.3 Interleukin-36 family and toll-like receptor 2
IL-36g is an inflammatory cytokine and a member of the IL-1 cytokine superfamily. IL36 is composed of three agonists, IL-36a, IL-36β, and IL-36g, and IL-36Ra, the IL-36 receptor
agonist(1). IL-36 agonists bind to receptors IL-36R and IL-1RAcP activating adaptor protein
myeloid differentiated protein (MYD88), mitogen-activated protein kinase (MAPK), and nuclear
factor-kappa B (NF-ΚB) signaling pathways (Figure 1-6) (1). These pathways then initiate target
gene regulation (1). IL-36 cytokines require post-translational modification by neutrophil
proteases to become active (1). IL-36 cytokines amplify keratinocyte inflammatory responses by
promoting both their own expression and expression of molecules related to Th17 signaling (1).
IL-36g upregulation has been shown in psoriasis, rheumatoid arthritis, irritable bowel disease,
and autoimmune disorders such as Sjögren’s syndrome (1).
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Figure 1-6. IL-36g signaling pathway
IL-36 agonist and accessory protein (IL36Ra) binding to the IL-36 receptor (IL-36R) and coreceptor (IL1-RAcP) forming a heterodimeric complex which binds to myeloid differentiated
protein 88 (MYD88), activating mitogen-activated-protein kinase (MAPK) and nuclear
transcription factor kappa B (NF-κB) signaling cascades inducing an inflammatory gene
response (1). Created with BioRender.com.
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Toll-like receptors are type I integral transmembrane glycoproteins that serve as
recognition molecules for many pathogens (28, 29). Animal model studies of periodontitis
suggest TLR overactivation plays a role in inflammatory destruction (2). TLR2 expression
upregulation has been linked to psoriatic lesions and multiple sclerosis (30, 31). TLR2 forms a
heterodimer with TLR1 and TLR6, initiating a signaling cascade for innate immune responses
(28, 29, 32). Activation of TLR2 triggers inflammatory signaling networks and induces the
production of pro-and anti-inflammatory signaling networks that play important roles in
pathogen clearance and tissue remodeling (33). TLR2 utilizes MYD-88, NFκB, and MAP
kinases to induce inflammatory cytokine genes (34). TLR2 is highly expressed in the basal layer
of the gingival epithelium and previous studies have shown that T. denticola primarily activates
the innate immune response via TLR2 (32, 33).
The relationship between T. denticola and gingival epithelial cells is poorly understood.
The object of this study is to establish a relationship between T. denticola and IL-36g cytokine
production and to better understand their role in chronic periodontitis. Based on preliminary
bioinformatics analysis, genes associated with type 1 interferon response, NFκB-dependent
signaling, and increased expression of proinflammatory cytokines have been significantly
induced in response to T. denticola infection. Of these, IL-36g is the most upregulated cytokine
expressed in human immortalized gingival keratinocyte (HIGK) cells when exposed to T.
denticola. This study is intended to establish IL-36g gene expression response to T. denticola and
gain a better understanding of the mechanisms through which T. denticola induces a
proinflammatory response.
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Chapter 2: Materials and Protocols
HIGK Cell Growth and Splitting
Human Immortalized Gingival Keratinocytes (HIGK) cells were grown in Corning T-75,
75 cm2 canted neck, non-pyrogenic flasks suspended in 10 ml of cell media either from a frozen
stock or from a previously developed cell line. Cells were stored in a VWR Air Jacketed CO2
Incubator at 37°C and 5% CO2. Cells were allowed to grow until 70-90 % confluence before
either being split or used for an infection and cell lines were terminated after passage 50.
Upon reaching confluency, cells were split by first removing the spent media from the
flask, and adding 5 mL of premade Corning 0.05% Trypsin, 0.53 mM EDTA 1X solution to
detach the cells from the flask. The flask was then placed in the incubator for 10 minutes.
Following the 10-minute incubation period, cells were checked under a microscope for
attachment, then 5 mL of cell media was added to the trypsinized T-75 flask. The 10 mL diluted
trypsin solution was then transferred from the flask to a 50 mL centrifuge tube and centrifuged at
1000x g for 10 minutes. Following centrifugation, the supernatant was removed and the pellet
disrupted with 1 mL cell media. Upon pellet disruption, a mL amount of cell media was added to
the tube depending on how dense the desired cells were intended to be. For our purposes we used
either 20 mL, 30 mL, 40 mL, 50 mL, depending on the experiment intended and the cell turnover
needed. Following resuspension, 10 mL of the resuspended cells were added to each desired T75 flask and placed in the incubator.
To split HIGK cells into 6-well plates for infection, the same procedure as above was
followed, with slight alteration. Instead of dispensing 10 mL of the resuspended HIGK cells, 1.5
mL of resuspended HIGK cells was pipetted into each well of a Corning 6-well Cell Tissue
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Culture Treated Plate and placed in the incubator. All HIGK cell work was conducted inside of a
cell culture hood to minimize contamination.
Cell Media
HIGK cell media was prepared using Lifeline Cell Technology 485 mL DermaLife Basal
Medium with DermaLife K LifeFactors Kit consisting of 0.5 mL rh Insulin LifeFactor, 15 mL LGlutamine LifeFactor, 0.5 mL Epinephrine LifeFactor, 0.5 mL Apo-Transferrin LifeFactor, 0.5
mL rh-TGF- a LifeFactor, 2 mL Extract PTM LifeFactor, and 0.5 mL Hydrocortisone
Hemisuccinate LifeFactor. The resulting pH of the cell media is 7.5 +/- 0.2.
Cell Count to Achieve Desired MOI
Prior to infection, a cell count of one well was taken to calculate the amount of
Treponema needed to fulfill the desired multiplicity of infection (MOI) for a given infection. The
denoted count well’s spent media was removed and 1 mL Trypsin was added. Following a 10minute incubation in the VWR Air Jacketed CO2 Incubator, 1 mL cell media was added to the
well to dilute the trypsin, and the 2 mL total was moved to a 15 mL centrifuge tube and
centrifuged at 1000x g for 10 minutes. Following centrifugation, the supernatant was removed
and cell pellets resuspended in 1 mL cell media. 10 µL of the resuspended HIGK pellet was
transferred to a 1.5 mL microcentrifuge tube and 10 µL gibco Trypan Blue Stain (0.4%) was
added, let stand 2 minutes. 10 µL of the stained HIGK cells was loaded into one well of a
CountessTM cell counting chamber slide, and inserted into the Countess II FL cell counter. The
cell count was then multiplied by the desired MOI and that product was divided by 3.5x108
cell/mL, which is a set standard of cells/mL at an OD= 0.2.
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𝐶𝑒𝑙𝑙 𝐶𝑜𝑢𝑛𝑡 𝑥 𝑑𝑒𝑠𝑖𝑟𝑒𝑑 𝑀𝑂𝐼 =

𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑚𝐿
= µL amount of Td to add per well
3.5 𝑥 10! 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑚𝐿

Treponema denticola Growth/ Maintenance
Treponema denticola (Td) was initially grown from a stock freeze back, but maintained
after initial growth. To start a culture from a freeze back, 500 µL of T. denticola freeze back and
10 mL NOS media were added to a 15 mL centrifuge tube and placed in the COY Lab Products
Vinyl Anaerobic Chamber. To start a new culture from an existing culture, 1 mL of the preexisting culture was pipetted to a new 15 mL centrifuge tube and 9 mL of NOS media was
added. After each use, an equal amount of NOS media was added to the tube to freshen the
existing culture. Caps on the tubes were left loose so mixture could become anaerobic in
chamber. Depending on amount of use and density, cultures were kept between 7 and 14 days
and then disposed of in a beaker of 100% bleach.
New Oral Spirochete Broth Media
500 mL of New Oral Spirochete Broth (NOS) media was prepared in a 500 mL beaker by
adding 300 mL DI water to the beaker and a stir bar, then placing the beaker on a stir/ hot plate at
32°C and 530 rpm. To the beaker, added: 6.25 g BBLTM Brain Heart Infusion, 5 g Tryptone, 2.5
g Yeast extract, 0.75 g reduced L-Glutathione, 0.5 g L-Cysteine, 0.125 g L-asparagine, 0.5 g
Sodium Bicarbonate, 1.5 mL 0.2% Thiamine Pyrophosphate, 5 mL Rabbit Serum, and 2 mL
Volatile Fatty Acids. Turned off the stir/ hot plate and filled the beaker to the 500 mL mark with
DI water. Cut the stir/ hot plate back to the same parameters and let mix with added DI water.
Filtered the broth through a Corning 1 L filtration system, on vacuum, then loosely capped to let
become anaerobic, and placed in anaerobic chamber.
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Optical Density and Infection Preparation of T. denticola
Optical density was used to measure Treponema growth. This was accomplished by
measuring OD600 of T. denticola using a 1 mL NOS media blank in a cuvette, and 1 mL of
intended T. denticola strain in a cuvette using the Thermo Scientific Genesys Visible
Spectrophotometer.
An OD of 0.2 is the set standard for infection that is equal to 3.5 x 108 cells/ mL. To
prepare T. denticola at an OD of 0.2 we first had to find the current OD of the strain being used
with the above method. Once OD was obtained, that OD was then used to calculate the µL
amount of the desired T. denticola strain to resuspend in 1 mL sterile PBS to achieve an OD of
0.2 using the equation below.
(0.2)(1 𝑚𝐿)
= µ𝐿 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑇𝑑 𝑠𝑡𝑟𝑎𝑖𝑛
𝑂𝐷 𝑜𝑓 𝑇𝑑 𝑠𝑡𝑟𝑎𝑖𝑛
The calculated amount of T. denticola was then added to a 1.5 mL microcentrifuge tube and
centrifuged for 5 minutes at 5000x g. Following centrifugation, the supernatant was removed and
T. denticola was resuspended in 1 mL sterile PBS.
Infection of HIGK Cells with T. denticola
HIGK cells were prepared in 6 well plates and cell counts were taken as described above.
Amount of T. denticola per well was calculated based on desired MOI. T. denticola was prepared
as described above for infection in 1 mL sterile PBS. Following preparation of HIGK cells and T.
denticola, the µL amount of T. denticola calculated using cell count was added to each
corresponding well and the plate placed back into the incubator. Infection duration was

25

Blake
monitored with a Fisher Scientific timer. Infection and incubation durations varied between
experiments. Following infection, if cells were to be incubated for protein secretion, spent media
was removed, each well was washed twice with 1 mL of PBS, and 1.5 mL fresh media was
added to each well and incubation was caried out. After incubation, supernatants were saved in
1.5 mL tubes and 250 µL RLT Lysis Buffer was added to each well, plates that were not
incubated had spent media removed and 250 µL was added, and rocked for 10 minutes. Plates
could then either be put in the -80°C or used for cDNA synthesis.
Multiple types of infection were performed, including: varying MOI at a single infection
duration and incubation period; single MOI with varying infection durations; single MOI with
single infection duration and varying incubation durations; different T. denticola strains with a
single MOI, infection duration, and incubation period; Telomerase Immortalized Gingival
Keratinocytes (TIGK) cells with varying MOI at a single infection and incubation duration; and
gene knockdowns. All infections were conducted in the same manor with only the expressed
changes being made.
SDS-PAGE Gel Electrophoresis and Western Blotting
Western blots were performed to see if T. denticola degrades IL-36g protein and for the
presence of an increase in IL-36g protein with changes in incubation duration. Both SDS-PAGE
gels were conducted the same way with only sample preparation being different. Once samples
were normalized and dyed, 5 µL of Precision Plus Protein Dual Color Standard or sample was
loaded into their designated well of a Mini-PROTEAN TGX Precast, 12- well comb gel that was
already set up in a BIO RAD Mini PROTEAN Tetra cell filled to the 2 gel line with 1X running
buffer. The gel holder was filled with 1X running buffer to the top of the gel cast. The gel was
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run at 200 volts until the bands reached the bottom of the gel, usually set for a period of 45
minutes and checked periodically for band progress.
Western blots were then prepared the same way for every gel. A single piece for every
gel of ImmunoBlot PVDF membrane for Protein Blotting was cut to the size of a piece of Mini
Trans-Blot filter paper and soaked in 70 percent methanol until the PVDF membrane changed to
a gray color. The 70 percent methanol was poured off of the PVDF membrane and DI water was
then added to cover the membrane which was placed on a rocker and held down for roughly
three minutes to rehydrate. A Pyrex tray was filled half full with transfer buffer and two pieces of
filter paper and two black sponges per PVDF membrane were saturated with transfer buffer. The
gel was then carefully removed from the cast by cracking open with a screw driver and removing
from one side of the cast. A transfer gel holder cassette was placed black side down into the
pyrex dish with transfer buffer and components were layered from bottom to top: sponge, filter
paper, gel, rehydrated PVDF membrane, filter paper, and sponge. The clear side of the cassette
was closed down and the two sides clamped together. The cassette was placed inside the
electrode with the clear side of the cassette facing the red side of the electrode, and then an ice
pack was placed in the Mini Trans-Blot cell along with the electrode. The cell was filled to the
blot line with transfer buffer and then ran at 100 volts for one hour.
5% milk was prepared with five grams of Dry Milk Powder in 100 mL PBST. Following
transfer, the PVDF membrane was removed from the cassette and soaked in a container of 5%
milk over night at 4°C. The next day, allowed the membrane to come to room temperature in the
5% milk it was stored on a rocker. Added 10 mL 5% milk and 20 µL anti-hIL-36g/IL-1F9
affinity purified goat IgG to a 15 mL centrifuge tube and vortexed. Poured out spent milk from
membrane and added enough PBST to the container to cover the membrane, and let rock for 5
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minutes. Repeated the PBST wash cycle two more times, pouring out old PBST between each,
and then added the anti-hIL-36g/IL-1F9, 5% milk mix to the PVDF membrane and let sit on
rocker for one hour. After an hour, poured out the contents of the tray and repeated the PBST
wash cycle as before. Made a 10 mL of 5% milk and 2 µL Anti-goat IgG-peroxidase antibody in
a 15 mL centrifuge tube, vortexed, and then added to the washed and drained PVDF membrane
and let rock for one hour. After one hour, poured out the mixture and repeated the PBST wash
cycle.
In a 15 mL centrifuge tube made a 4 mL 1:1 mixture of SuperSignal West Pico PLUS
Stable Peroxide and SuperSignal West Pico PLUS Luminol/ Enhancer. Poured the peroxide/
luminol mix over the PVDF membrane in the dark room and let incubate for two minutes, then
ran in Chemidoc on chemiluminescence setting for 30 seconds.
IL-36g Degradation
Samples to see if T. denticola degrades IL-36g were prepared differently for gel
electrophoresis than samples for increased presence of IL-36g. T. denticola strains 35405, the
generic strain used, and CCE, which is the dentilisin deficient strain, were prepared the same as
in infection preparation, but were resuspended is 20 µL PBS. A 1.5 mL centrifuge tube was filled
with 20 µL PBS as a control. Three sets of PCR strips were labelled as 0 minutes, 30 minutes,
and 1 hour, and a tube on each strip labelled: PBS, 405, and CCE. 10 µL BME was added to a
tube of 5X-SDS-PAGE running buffer, and then 1 µL of this solution was added to each labelled
tube of each strip. 1 µL of stock 200 ng/µL IL-36g protein was added to the prepared 1.5 mL
tubes of PBS, 405, and CCE, and then vortexed. 5 µL of each was then added to their
corresponding tube on the 0 minute PCR strip and placed in the thermocycler for 7 minutes at
100°C. At both 30 minutes and 1 hour, 5 µL of each sample was added to its corresponding tube

28

Blake
on the labelled PCR strip and placed in the thermocycler for 7 minutes at 100°C. The samples
were then ready for gel electrophoresis.
SAAPFNA (Dentilisin) Assay
T. denticola strains were grown in NOS media for 48 hours prior to assay. ODs of each
strain were taken and the amount of each strain needed to get an OD of 0.5 in 1 mL of
SAAPFNA assay buffer was calculated and centrifuged in 1.5 mL microcentrifuge tubes for 5
minutes at 5,000x g. 500 mL SAAPFNA assay buffer was made with 3 grams Tris, 3 grams
sodium chloride, and 0.055 grams calcium chloride and brought to a pH of 8 with hydrochloric
acid, and to volume with DI water, then vacuum filtered. 50 µL of assay buffer or different
strains was added to five wells each of a 96-well plate, and then 50 µL of 100 µL of reconstituted
SAAPFNA (N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide) from Sigma-Aldrich mixed in 10 mL
assay buffer prepared in a reagent reservoir was added to each well. Plates incubated at room
temperature for one hour, then ran in the iD3 SpectraMax on 405nm absorbance setting. The
average absorbance values were then plotted. Chymotrypsin cleaves on the C-terminal of
phenylalanine, tryptophan, and tyrosine. This assay utilizes this my measuring the amount of
fluorescents produced by p-nitroanilide, a colorimetric organic compound that fluoresces,
cleaved from the N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide substrate. More dentilisin activity
cleaves more p-nitroanilide, thus producing more fluorescents.
cDNA Synthesis
Prior to bench work, bench top and equipment were sprayed down with RNAse away,
and RNA designated pipette tips were used. Following 10 minute rocking period, or thawing on
rocker if stored in the -80°C freezer, 250 µL of 70% ethanol was added to each well, plate
swirled to mix ethanol and RLT buffer, and incubated at room temperature for two minutes. Full
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contents of each well were removed, added to correspondingly labelled spin cartridges, and
centrifuged for 20 seconds at 12,000x g. Disposed of flow through from collection tube, added
700 µL Wash Buffer I, and centrifuged 20 seconds at 12,000x g. Disposed of flow through and
collection tube, added 500 µL Wash Buffer II to spin cartridge in a new collection tube and
centrifuged 20 seconds at 12,000x g. Again disposed of flow through and added 500 µL Wash
Buffer II a second time, and centrifuged two and a half minutes to dry out membrane. Disposed
of flow through and collection tube and spin cartridges were placed in correspondingly labelled
recovery tubes. 100 µL RNAse free water was added to each spin cartridge, incubated at room
temperature for one minute, then centrifuged 20 seconds at 12,000x g.
RNA concentrations were taken using 2 µL RNAse free water as the blank, and then 2
µL of each sample with the NanoDrop One. Concentrations were used to calculate a normalized
concentration to set all samples to use. Normalized concentration was determined based on the
sample with the lowest concentration of RNA, typical concentrations were 100 ng, 250 ng, 500
ng, and 1000 ng. Normalized concentration was then divided by RNA concentration of each
sample to determine the amount of sample to add to a labelled, PCR tube for cDNA synthesis.
Each sample was brought to a 10 µL total with nuclease-free water.
cDNA reverse transcriptase master mix was made using 2 µL/ sample 10X Reverse
Transcriptase Buffer, 2 µL/ sample 10X Reverse Transcriptase Random Primers, 0.8 µL/ sample
25X dNTP mix, 1 µL/sample Reverse Transcriptase, and 4.2 µL/ sample Nuclease-free water. 10
µL of the master mix was then added to each sample PCR tube, vortexed, and then run in the
Thermocycler on High Capacity cDNA Synthesis setting. Samples were then diluted to 5 ng/µL
with Nuclease-free water and ready for qPCR.
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Real Time qPCR
qPCR was performed in a MicroAmp Optical 96-well Reaction plate for cDNA samples.
9 µL of a prepared assay mix of 5 µL/ sample TaqMan Fast Advanced Master Mix, 0.5 µL/
sample of the desired assay, and 3.5 µL/sample of Nuclease-Free water was pipetted into each
well of the assigned three columns for a given assay. 1 µL of each sample was then pipetted into
designated wells so there were three replicates of each assay for each sample. Plates were
covered with an Optical Adhesive Cover and centrifuged approximately 15 seconds at 1,000x g
to bring all contents to the bottom of each well. The plate was then run in the QuantStudio 3 on
10 µL sample, ΔΔCt, fast, TaqMan reagent, GAPDH exogenous control, ROX passive reference
setting. Data was analyzed for fold change compared to the control and plotted in excel.
2X TLR2 Knockdowns
Gene silencing, or knockdowns, were prepared using siRNA. 3 µL/ well of the desired
knock down siRNA was mixed with 150 µL/ well of warmed cell media and vortexed. An
RNAiMAX mix was made with 9 µL Lipofectamine RNAiMAX Reagent per well and 150 µL
cell media per well and vortexed. A 1:1 amount of RNAiMAX mix was added to each silencer
tube, vortexed, and incubated at room temperature for 5 minutes. A negative control silencer was
used for each infection, and each infection included a knockdown well infected with T. denticola
and one without. For the 2X TLR2 knockdown the amount per each well was doubled to reach
the desired amount of 200 µM of siRNA per well. Infection was carried out as before from this
point.
Statistical Analysis
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All statistical analysis and graphing was conducted using GraphPad PRISM 9 software.
Data was analyzed via a One-way ANOVA test and samples were compared to each other using
Tukey’s range test.
Molecular Reagents used in this study
Western Blotting
•

R&D Systems anti-hIL-36g/IL-1F9 Cat#: AF2320

•

Sigma-Aldrich Anti-Goat IgG Cat#: A5420

Assays- TaqMan Gene Expression Assays
•

GAPDH-VIC: Hs02786624_g1

•

IL-36g: Hs00219742_m1

•

IL-6: Hs00174131_m1

•

IL-8: Hs00174103_m1

•

TLR2: Hs02621280_s1

Gene Silencing
•

Ambion TLR2 silencer ID: 107052

•

Ambion Negative Control Cat#: AM4635
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Chapter 3: Results
3.1 IL-36g degradation
Preliminary RNA-sequencing data showed IL-36g to be the most upregulated cytokine
when HIGK cells were infected with T. denticola. The goal of this study was to confirm this
relationship does occur. Before approaching the question of does T. denticola induce IL-36g
expression, it first needed to be determined if T. denticola could degrade IL-36g. T. denticola’s
highly proteolytic characteristic due to dentilisin begs the question of if it will degrade IL-36g
before there is a chance to induce an inflammatory response. This was accomplished by
performing a degradation experiment comparing T. denticola 35405, T. denticola CCE (the
dentilisin deficient strain of T. denticola), and PBS control at OD600 of 0.2. All three were
exposed to 1 µL of 200ng/µL recombinant IL-36g for zero minutes, 30 minutes, and one-hour
post-exposure. A western blot was performed for the presence of IL-36g. The western blot
showed no change in the presence of IL-36g, meaning T. denticola does not degrade IL-36g
(Figure 3-1). The experiment was performed again with an OD600 of 0.4, and again no
degradation was observed despite doubling the amount of T. denticola present(Figure 3-2).
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Figure 3-1. T. denticola degradation at OD600 of 0.2
Western Blot of T. denticola 35405, CCE, and PBS at an OD600
of 0.2, exposed to recombinant IL-36g for zero minutes, 30
minutes, and one hour.
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Figure 3-2. T. denticola degradation at OD600 of 0.4
Western Blot of T. denticola 35405, CCE, and PBS at an OD600 of
0.4, exposed to recombinant IL-36g for zero minutes, 30 minutes,
and one hour.
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3.2 T. denticola induction of IL-36g and varying MOI infection
After determining T. denticola does not degrade IL-36g, we could then focus on the
question we set out to answer, is IL-36g induction in HIGK cells increased when infected with T.
denticola? Since the relationship between T. denticola and oral epithelial cells is poorly
understood, no prior infection duration had been established. An infection duration of six hours
with an eighteen-hour incubation period was determined as an initial starting point at varying
multiplicities of infection (MOI). These infections were carried out at MOIs 10, 50, 100, and
200, and allowed to incubate for 18 hours following infection. Supernatants for each MOI were
collected and saved for protein testing at a later time. Three biological replicates were completed
for each MOI at the set infection and incubation time points.
Real-time quantitative PCR was performed for each replicate for upregulation in the
expression of IL-36g, IL-36a (another IL-36 subunit), IL-1RAP (an accessory protein that forms
a heterodimer with the IL-36 receptor), IL-1RL2 (the IL-36 receptor), IL-6 (an inflammatory
cytokine), IL-8 (inflammatory chemokine), and IRF7 (a transcription factor). Of the genes
targeted for RT-qPCR, IL-36g, IL-6, IL-8, and IRF7 were all significantly upregulated in
response to T. denticola infection (Figures 3-3 through 3-6). IL-6 is an inflammatory cytokine
that is upregulated in response to T. denticola (35). IL-8 is a chemokine that attracts cells to
inflammatory sites and has been upregulated in T. denticola infection (36). IRF7 is a
transcription regulatory factor that plays an important role in regulating Type-1 interferon
response (37). IL-6, IL-8, and IRF7 are all differentially expressed in the RNA sequencing data
that led us to identify IL-36g as a target of interest. We targeted these three genes in qPCR to
determine if the same response from the RNA sequencing data was repeatable. The highest gene
expression was seen at an MOI of 200 among all four statistically significant findings. Because
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chronic periodontitis is a dysbiotic biome, with an increasing T. denticola presence, an MOI 200
is not an excessive amount of T. denticola exposure (17). This experiment established an MOI of
200 as being the point where the most induction of IL-36g is expressed and determined the MOI
to use for experiments moving forward.
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Figure 3-3. IL-36g expression in varying MOI sample
Average fold change of IL-36g relative to a no infection control of
the varying MOI biological replicate experiments. The no
infection sample was set to one. * is P< 0.05 and ** is P< 0.005
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Figure 3-4. IL-6 expression in varying MOI sample
Average fold change of IL-6 relative to a no infection control of
the varying MOI biological replicate experiments. The no
infection sample was set to one. ** is P< 0.05
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IL-8 Expression in Varying MOI HIGK Infections

Figure 3-5. IL-8 expression in varying MOI sample
Average fold change of IL-8 relative to a no infection control of
the varying MOI biological replicate experiments. The no
infection sample was set to one. * is P<0.05, ** is P< 0.01, and
*** is P<0.0005.
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Figure 3-6. IRF7 expression in varying MOI sample
Average fold change of IRF7 relative to a no infection control of
the varying MOI biological replicate experiments. The no
infection sample was set to one. * is P<0.05, ** is P< 0.005, and
*** is P<0.0005.
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3.3 Different T. denticola strain infection
After determining the MOI that induced the most IL-36g upregulation, the next
question was, is this a unique relationship only seen between T. denticola 35405, or is the
applicable to multiple strains of T. denticola. To test this, the same experimental design as the
varying MOI was used, a six-hour infection and eighteen-hour incubation at an MOI of 200 with
supernatants saved post-incubation for protein testing at a later time. T. denticola strains
35405, CCE, CF170, SP48, SP50, and SP55 were compared. The same genes targeted in the
varying MOI experiments were targeted using RT-qPCR for each strain infection. Three
biological replicates were obtained and averages of fold change in expression relative to the
non-infected control well were graphed in GraphPad PRISM 9. Of the genes targeted, IL-36g
and IRF7 were the only two genes significantly upregulated. IL-36g was highly variable in its
expression in response to CCE and SP55, and these two strains were thus excluded. Highest
expression of IL-36g was induced by SP50 with 35405 being almost equivalent to SP48 (Figure
3-7). IRF7 was consistently upregulated among all T. denticola strains, having the most
upregulation with Sp50 infection (Figure 3-8). 35405 upregulation was in the lower half of the
upregulation averages compared to other strains. This data shows IL-36g upregulation is not
unique to 35405 and is induced by multiple strains of T. denticola.
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Figure 3-7. IL-36g expression in different T. denticola strain
sample
Average fold change of IL-36g relative to a no infection control of
the differing T. denticola strain biological replicate experiments.
The no infection sample was set to one. ** is P< 0.01
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Figure 3-8. IRF7 expression in different T. denticola strain
sample
Average fold change of IRF7 relative to a no infection control of
the differing T. denticola strain biological replicate experiments.
The no infection sample was set to one. ** is P< 0.005
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3.4 Dentilisin activity
35405 is the main strain used in all other experiments, yet it was not the T. denticola
strain with the highest gene expression. This begged the question of if dentilisin activity plays a
role in infection and the induction of IL-36g. To answer the question, a SAAPFNA assay was
conducted to measure the dentilisin activity of each strain. SP50 induced both the highest
amount of IL-36g expression and IRF7 expression among the strains tested. However, SP50 was
among the lower half of samples in dentilisin activity. As predicted, the dentilisin deficient
strain, CCE, showed the lowest expression of dentilisin activity. 35405 exhibited the highest
amount of dentilisin activity (Figure 3-9). Due to the differences between SP50 high induction of
IL-36g, but lower dentilisin activity, and 35405’s comparatively lesser IL-36g expression and
highest dentilisin activity, it is concluded that dentilisin activity does not play a major role in the
induction of IL-36g.
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Dentilisin Activity In Different
T. denticola Strains

Figure 3-9. Dentilisin activity among different T. denticola
strains
Average fold change of dentilisin activity relative to a SAAPFNA
buffer control of the differing T. denticola strains. The SAAPFNA
buffer sample was set to one. **** is P< 0.0001.
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3.5 IL-36g expression in TIGK cells
Now that it is established that multiple strains of T. denticola induce IL-36g, it needed to
be seen that T. denticola could induce IL-36g in multiple different cell lines. To start, we first
looked at telomerase immortalized gingival keratinocyte (TIGK) cells. This experiment was
conducted the same way as the initial varying MOI experiment, a six-hour infection with an
eighteen-hour incubation period at MOIs 10, 50, 100, and 200. Supernatants were again saved
for protein analysis at a later time. RT-qPCR was performed for IL-36g expression and found
that IL-36g gene expression is upregulated in response to T. denticola infection (Figure 3-10).
Due to the slow-growing nature of TIGK cells, only two biological replicates were able to be
performed. A third biological replicate will need to be completed in the future, along with
looking at IL-36g expression in other cell lines.
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Figure 3-10. IL-36g expression in TIGK cell line varying MOI
infection
Average fold change of TIGK cells infected with T. denticola
35405 for six-hour infection and 18-hour incubation compared to
no infection control. ** is P< 0.01.
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3.6 Infection duration with highest IL-36g expression
After establishing IL-36g expression is upregulated with T. denticola infection,
the MOI at which highest IL-36g expression is observed, the difference in induction
caused by different strains, and dentilisin’s role in the induction of IL-36g, we next
wanted to establish at which point IL-36g expression was highest. This was
accomplished by infecting HIGK cells with T. denticola 35405 at an MOI of 200 for 30
minutes, 1 one hour, two hours, and four hours with no incubation period. RT-qPCR was
then conducted for the expression of IL-36g. There is a significant difference in
expression of IL-36g at both two and four hours infection duration compared to the no
infection control (Figure 3-11). Three biological replicates were performed for this
experiment showing the highest IL-36g expression at four hours of infection.
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Figure 3-11. IL-36g expression in varying infection duration
samples
Average fold change of IL-36g expression in varying infection
duration experiment relative to the no infection control. Control
was set to one. * is P< 0.05.
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3.7 TLR2 Knockdown
Establishing what time point IL-36g expression is highest was necessary for determining
an appropriate infection duration to look at the mechanism of IL-36g signaling. Because IL-36g
is mostly highly induced at four hours, we chose an infection duration of two hours for looking
at the signaling pathway. This is because the signal is first induced, then expressed, so we chose
a time point well before the maximal induction of IL-36g. Because it has been shown that T.
denticola primarily activates the innate immune response via TLR2, TLR2 was the focus as the
first target in the signaling pathway. 200 µM of TLR2 siRNA was used to knock down TLR2
expression 24 hours prior to infection with 35405. SiRNA and media were removed prior to
infection and the infection was conducted for a two-hour duration with no infection and siRNA
negative controls. RT-qPCR for TLR2 and IL-36g were conducted for each of the three biological
replicates. The TLR2 knockdown without T. denticola infection was used to determine if TLR2
was efficiently suppressed. There was a significant knockdown of both TLR2 when compared to
the control without T. denticola infection and with T. denticola infection(Figure 3-12). There
was also a significant amount of knock down of IL-36g in the TLR2, T. denticola infected sample
compared to the T. denticola infected control(Figure 3-13). Because there is a decrease in IL36g expression when TLR2 is suppressed, this data shows that TLR2 plays a role in IL-36g
signaling.
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TLR2 Expression in 200 µM TLR2 siRNA knockdown

Figure 3-12. TLR2 expression in 200µM TLR2 siRNA
knockdown infection
Average fold change of TLR2 expression in negative control and
TLR2 siRNA knockdown samples with and without T. denticola
infection. * is P<0.05 and ** is P< 0.01.
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IL-36g Expression in 200 µM TLR2 siRNA knockdown

Figure 3-13. IL-36g expression in 200µM TLR2 siRNA
knockdown infection
Average fold change of IL-36g expression in negative control and
TLR2 siRNA knockdown samples with and without T. denticola
infection. ** is P<0.01 and *** is P< 0.001.

53

Blake
Chapter 4: Discussion
Prior to this study, the relationship between T. denticola and oral epithelial cells has
been poorly understood, and not well characterized in the literature. This study found that T.
denticola does induce IL-36g gene expression as predicted based on the RNA sequencing data
performed initially. It was determined that IL-36g expression is induced by varying multiplicities
of infection in human immortalized gingival keratinocytes, with the highest amount of
expression seen at an MOI of 200. Along with IL-36g induction, the transcription factor IRF7,
cytokine IL-6, and chemokine IL-8 showed statistically significant induction in varying MOI
infection. After establishing MOI for future infections, we established different strains of T.
denticola also induce IL-36g production. IRF7 was also significantly upregulated in the varying
MOI test. Of the strains tested, T. denticola SP50 showed the highest amount of IL-36g
induction. This begged the question of dentilisin’s presence in the SP50 strain, and
subsequently its role in IL-36g induction. Upon SP50’s higher expression of IL-36g than 35405,
the main strain used in experimentation, we examined the dentilisin activity of all the strains
tested and did so using a SAAPFNA assay. We found that dentilisin activity was highest in T.
denticola 35405. Since dentilisin activity is highest when exposed to 35405 and IL-36g
expression is highest when exposed to SP50, it is concluded that dentilisin activity does not
affect IL-36g expression.
Having established IL-36g expression in response to multiple T. denticola strains, the
next question was is this repeatable in other cell lines. To accomplish this, we started by looking
at T. denticola 35405 infection of telomerase immortalized gingival keratinocytes, or TIGK cells.
This experiment was conducted the same as the varying MOI experiment and found IL-36g
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expression is increased in response to T. denticola infection. More trials in TIGK cells are needed
to establish this relationship with certainty. Future studies need to be performed in other cell
lines as well. A cell line to look at next is fibroblasts, another host cell imperative for the
integrity of periodontal bone and connective tissue (38).
Now that IL-36g upregulation in response to multiple T. denticola strains, and in
multiple cell lines is determined, the next focus is the IL-36g signaling mechanism. First, it
needed to be established when the highest amount of IL-36g induction occurred, establishing a
time frame for when to target signaling. IL-36g induction was highest at four hours post T.
denticola 35405 infection at an MOI of 200. Because signaling occurs before an induced
response is seen, two hours was chosen to look at TLR2 expression. There is conflicting data on
the role TLR2 and TLR4 play in IL-36g signaling. Bassoy et al. recognize IL-36g signaling to be
dependent on TLR4, whereas Ruby et al. state T. denticola stimulates NF-κB through TLR2 and
not TLR4 (33, 39). Based on the experimental findings in our original knockdown for siRNA
effectiveness, there was no presence of TRL4, leading us to focus on TLR2. TLR2 expression was
significantly knocked down in comparison to the negative control when infected with T.
denticola. There was a reduction in IL-36g induction in the TLR2 knockdown HIGK cells
compared to the T. denticola infected negative control, however, not to a statistically significant
amount. Further studies need to be conducted targeting TLR2 to determine the relationship.
Limitations and Future Directions
Regarding limitations to the study, a sandwich enzyme-linked immunosorbent assay
(ELISA) was conducted for IL-36g protein expression. The sandwich ELISA was too variable
among standards and protein samples alike to identify IL-36g protein concentrations
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accurately. Saved supernatants can be used in the future with a more amplified method of
detecting protein. MYD88 which is an accessory protein activated upon TLR2 receptor binding,
was tested for using siRNA the same way TLR2 was. However, even double the amount of
MYD88 siRNA did not appropriately silence MYD88 expression. Because MYD88 is directly
involved in the TLR2 receptor signaling pathway, there needs to be further experiments to
determine the relationship. NFκB stimulates inflammatory cytokine production downstream of
MYD88, was also silenced using siRNA (40). The data for these experiments were also variable
between each experiment with adequate knockdown and some with almost no knockdown.
Both MYD88 and NFκB are involved in the TLR2 signaling pathway and need future studies to
solidify their role in T. denticola induced IL-36g signaling. A new form of gene silencing may
need to be employed, with possibly multiple different siRNA. The cell media used is at a pH
around 7.5, whereas oral cavity pH is maintained between pH 6.7 and 7.3 by saliva (41). The
slight difference in the pH may be enough to elicit a different response, even though alkalinity is
favorable for plaque formation (41).
This study was a preliminary, in vitro study to establish IL-36g production in response to
T. denticola infection. Further studies are needed to establish the full signaling pathway
employed to elicit IL-36g upregulation. Because the oral cavity is such a diverse biome of many
bacteria, host proteins and enzymes, and different cell types, studies incorporating more oral
bacteria and salivary enzymes need to be conducted. A cell model mimicking layers of the
gingiva should also be explored. Periodontal disease is a diverse and complex disease, that can
vary between individuals. It is overzealous to propose a future cure for periodontal disease, but
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with a better understanding of the establishment and relationship of the plaque biofilm, there
will be improved methods of treatment and prevention.
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